In 2024, key federal healthcare regulations and policy developments—related to health insurance, privacy protections, reimbursement, biosimilar use and more—shaped the landscape of the practice of rheumatology in several important ways.
Federally Funded Providers Must Provide Language Assistance Services by July 5
By July 5, all providers who participate in federally funded healthcare programs, including Medicare and Medicaid, must provide language assistance programs for patients to meet requirements of Section 1557 of the Affordable Care Act.
Telemedicine Flexibilities for Controlled Substance Prescriptions Extended Through 2025
A third extension of telemedicine flexibilities will continue to allow prescription of controlled substances via telemedicine without an in-person visit through the end of 2025.
Status Check: Non-Compete Agreements in Healthcare
The FTC issued a Final Rule that banned non-compete agreements, but the rule was recently halted by a nationwide injunction from a federal court in Texas.
‘Don’t Block Patient Access to Records,’ says HHS to Healthcare Providers
The Department of Health & Human Services has released a final rule that would penalize healthcare providers who interfere with a patient’s access to, exchange or use of their electronic health information.
Unpacking the Court: An Analysis of Recent Supreme Court Decisions
Two recent Supreme Court decisions, Trump v. United States and Loper Bright Enterprises v. Raimond, have broad implications for administrative authority and regulatory advocacy. Joseph Cantrell, JD, analyzes how these decisions may affect the relative power of the different branches of government.
HHS Final Rule Reinstates ACA Nondiscrimination Provisions
Effective July 5, discrimination based on race, color, national origin, sex, age and disability by healthcare programs receiving federal assistance is once again prohibited. The application of Section 1557 to all HHS health programs and activities and state and federally facilitated exchanges, which had been weakened by the Trump administration, has been reinstated.
What’s Next for Telehealth after the COVID-19 Public Health Emergency?
Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…
In the Wake of Dobbs v. Jackson Women’s Health Organization
Since the Supreme Court ruling in June 2022 overturning 50 years of precedent protecting abortion as a constitutional right (Dobbs v. Jackson Women’s Health Organization), states are enacting and implementing new laws to regulate abortion, and medical organizations and healthcare providers are assuming the large task of understanding what the new laws mean for their…
The Pandemic’s End: What Do the Ending National Emergency Proclamations Mean for Healthcare?
As COVID-19 case counts fade from the headlines and people return to their pre-pandemic routines, rheumatologists and rheumatology professionals may be wondering what “the end” of COVID-19 is going to look like for them. Much of that answer lies in the status of the federal emergencies that have been declared in response to COVID-19. These…
- 1
- 2
- 3
- …
- 19
- Next Page »